Elanco Animal Health Inc (ELAN)
14.04
-0.15
(-1.06%)
USD |
NYSE |
Nov 14, 16:00
14.04
0.00 (0.00%)
After-Hours: 19:57
Elanco Animal Health Total Liabilities (Quarterly): 6.76B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 6.76B |
June 30, 2024 | 7.822B |
March 31, 2024 | 7.963B |
December 31, 2023 | 8.139B |
September 30, 2023 | 8.21B |
June 30, 2023 | 8.376B |
March 31, 2023 | 8.289B |
December 31, 2022 | 8.202B |
September 30, 2022 | 8.203B |
June 30, 2022 | 8.461B |
March 31, 2022 | 8.639B |
December 31, 2021 | 8.97B |
September 30, 2021 | 8.883B |
June 30, 2021 | 8.853B |
Date | Value |
---|---|
March 31, 2021 | 8.981B |
December 31, 2020 | 9.217B |
September 30, 2020 | 8.893B |
June 30, 2020 | 3.224B |
March 31, 2020 | 3.066B |
December 31, 2019 | 3.439B |
September 30, 2019 | 3.336B |
June 30, 2019 | 3.591B |
March 31, 2019 | 3.551B |
December 31, 2018 | 3.759B |
September 30, 2018 | 4.074B |
June 30, 2018 | 990.80M |
December 31, 2017 | 1.16B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.066B
Minimum
Mar 2020
9.217B
Maximum
Dec 2020
7.629B
Average
8.250B
Median
Total Liabilities (Quarterly) Benchmarks
Baxter International Inc | 18.60B |
Edwards Lifesciences Corp | 3.360B |
Syros Pharmaceuticals Inc | 96.12M |
Opus Genetics Inc | 4.198M |
Edgewise Therapeutics Inc | 21.17M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 13.28B |
Shareholders Equity (Quarterly) | 6.523B |
Debt to Equity Ratio | 0.6679 |
Current Ratio | 2.548 |
Net Debt Paydown Yield | 4.70% |